Authors:
Mauceri, HJ
Seetharam, S
Salloum, RM
Vokes, E
Weichselbaum, RR
Citation: Hj. Mauceri et al., Treatment of head and neck and esophageal xenografts employing Alimta (R) and concurrent ionizing radiation, INT J ONCOL, 19(4), 2001, pp. 833-835
Authors:
Nemunaitis, J
Khuri, F
Ganly, I
Arseneau, J
Posner, M
Vokes, E
Kuhn, J
McCarty, T
Landers, S
Blackburn, A
Romel, L
Randlev, B
Kaye, S
Kirn, D
Citation: J. Nemunaitis et al., Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer, J CL ONCOL, 19(2), 2001, pp. 289-298
Authors:
Kornblau, S
Benson, AB
Catalano, R
Champlin, RE
Engelking, C
Field, M
Ippoliti, C
Lazarus, HM
Mitchell, E
Rubin, J
Stiff, PJ
Vokes, E
Wadler, S
Citation: S. Kornblau et al., Management of cancer treatment-related diarrhea: Issues and therapeutic strategies, J PAIN SYMP, 19(2), 2000, pp. 118-129
Authors:
Fossella, FV
DeVore, R
Kerr, RN
Crawford, J
Natale, RR
Dunphy, F
Kalman, L
Miller, V
Lee, JS
Moore, M
Gandara, D
Karp, D
Vokes, E
Kris, M
Kim, Y
Gamza, F
Hammershaimb, L
Citation: Fv. Fossella et al., Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated withplatinum-containing chemotherapy regimens, J CL ONCOL, 18(12), 2000, pp. 2354-2362
Authors:
Gandara, DR
Vokes, E
Green, M
Bonomi, P
Devore, R
Comis, R
Carbone, D
Karp, D
Belani, C
Citation: Dr. Gandara et al., Activity of docetaxel in platinum-treated non-small-cell lung cancer: Results of a phase II multicenter trial, J CL ONCOL, 18(1), 2000, pp. 131-135
Authors:
Lad, T
Rosen, F
Sciortino, D
Brockstein, B
Keubler, JP
Arietta, R
Vokes, E
Citation: T. Lad et al., Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer, INV NEW DR, 18(3), 2000, pp. 261-263